glp-1 nausea class action in michigan At least 3,000 patients have filed lawsuits against the companies behind GLP -1 weight loss drugs, alleging severe health risks, including blindness. NewsNation's Brooke Shafer has the story on "Morning America." As demand for GLP-1 pills
Description
But with so many options available, ho...

If youre working in this space (or want to be), come be part of the conversation

Glucagon-like peptide-1 (GLP-1) receptor agonists, widely prescribed for type 2 diabetes and weight management, are known for their metabolic benefits but may have unrecognized side effects

Results Reducing dose frequency does not commensurately reduce weight loss

The European Medicines Agency has issued a positive recommendation on the same indication